Factors associated with achieving DFD status included younger age, fewer ASMs at baseline, diagnosis of Doose syndrome, and diagnosis of GLUT-1 deficiency. The gene discussed is SLC2A1; the disease is epilepsy with myoclonic atonic seizures.